Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mersana Therapeutics

Mersana Therapeutics
2001 FOUNDED
PUBLIC STATUS
81-90 EMPLOYEES
MRSN STOCK SYMBOL
$8.05 SHARE PRICE (As of Friday Closing)
Description

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines.

Website
Formerly Known As
Nanopharma
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 840 Memorial Drive
  • Cambridge, MA 02139
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mersana Therapeutics’s full profile, request a free trial.

Mersana Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.32 - $8.93 $365M $7.61 -$1.25 369K 45.3M

Mersana Therapeutics Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value (43,935) 8,525 334,910
Revenue 43,270 10,594 17,545 25,171
EBITDA (35,069) (64,398) (38,689) (13,166)
Net Income (34,394) (64,257) (38,707) (13,700)
Total Assets 121,655 78,502 130,715 105,087
Total Debt 8,239 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mersana Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mersana Therapeutics‘s full profile, request access.

Request full access to PitchBook

Mersana Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Mersana Therapeutics‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Mersana Therapeutics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000 000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
000000000 00000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000000 00000
0000000 00000 0000 Formerly VC-backed San Diego, CA 00 000.00 00000000 000.00
000 0000000000000 Venture Capital-Backed Chester, United Kingdom 00 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Mersana Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Mersana Therapeutics‘s full profile, request access.

Request full access to PitchBook

Mersana Therapeutics Executive Team (18)

Name Title Board
Seat
Contact
Info
Anna Protopapas Chief Executive Officer & Board Member
Ashish Mandelia Chief Accounting Officer
Timothy Lowinger Ph.D Chief Scientific Officer
Eva Jack Executive
Brian DeSchuytner Senior Vice President

8 Former Executives

You’re viewing 5 of 18 executives. Get the full list »

Mersana Therapeutics Board Members (17)

Name Representing Role Since Contact
Info
Andrew Hack Ph.D Self Board Member 000 0000
Anna Protopapas Mersana Therapeutics Chief Executive Officer & Board Member 000 0000
David Mott Self Chairman & Board Member 000 0000
Kristen Hege MD Self Board Member 000 0000
Lawrence Alleva Self Board Member 000 0000

12 Former Board Members

You’re viewing 5 of 17 board members. Get the full list »